Clinical Trial Update: Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating the efficacy and safety of Telitacicept for systemic sclerosis, focusing on the diffuse cutaneous form. The study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Cutaneous Systemic Sclerosis
• Systemic Sclerosis

Drugs mentioned

• Telitacicept

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Diffuse Cutaneous Systemic Sclerosis | Phase 2 | Status: RECRUITING